These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15363482)

  • 1. Normalization of impaired cognitive functions failed to improve clinical symptomatology in a schizophrenic patient.
    Holzer L; Halfon O
    Eur Psychiatry; 2004 Sep; 19(6):384-6. PubMed ID: 15363482
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of olanzapine on cerebellar functional connectivity in schizophrenia measured by fMRI during a simple motor task.
    Stephan KE; Magnotta VA; White T; Arndt S; Flaum M; O'Leary DS; Andreasen NC
    Psychol Med; 2001 Aug; 31(6):1065-78. PubMed ID: 11513374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.
    Vayısoğlu S; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Karcı O; Gürel SC; Yazıcı MK
    Schizophr Res; 2013 Jan; 143(1):207-14. PubMed ID: 23217729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of antipsychotic therapy on the cognitive functions of schizophrenic patients].
    Tybura P; Mak M; Samochowiec A; Pełka-Wysiecka J; Grzywacz A; Grochans E; Zaremba-Pechmann L; Samochowiec J
    Psychiatr Pol; 2013; 47(4):567-78. PubMed ID: 24946464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive factors in schizophrenia: causes, impact, and treatment.
    Meltzer HY
    CNS Spectr; 2004 Oct; 9(10 Suppl 11):15-24. PubMed ID: 15475873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deficits as treatment targets in schizophrenia.
    Gold JM
    Schizophr Res; 2004 Dec; 72(1):21-8. PubMed ID: 15531404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
    Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
    Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications.
    Savina I; Beninger RJ
    Schizophr Res; 2007 Aug; 94(1-3):128-38. PubMed ID: 17560766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study.
    Broerse A; Crawford TJ; den Boer JA
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):454-60. PubMed ID: 12426415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms.
    Gurpegui M; Alvarez E; Bousoño M; Ciudad A; Carlos Gómez J; Olivares JM
    Eur Neuropsychopharmacol; 2007 Nov; 17(11):725-34. PubMed ID: 17543505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophrenia.
    Riedel M; Müller N; Spellmann I; Engel RR; Musil R; Valdevit R; Dehning S; Douhet A; Cerovecki A; Strassnig M; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2007 Oct; 257(7):402-12. PubMed ID: 17629725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine.
    Littrell KH; Petty RG; Hilligoss NM; Kirshner CD; Johnson CG
    Schizophr Res; 2004 Feb; 66(2-3):201-2. PubMed ID: 15061258
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurological soft signs and their relationship to cognitive and clinical efficacy of atypical antipsychotics in schizophrenia.
    Das M; Kumari V; Soni W; Ettinger U; Binneman B; Hughes C; Mehrotra R; Sharma T
    Schizophr Bull; 2004; 30(2):241-53. PubMed ID: 15279043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement in cognition associated with novel antipsychotic drugs: a direct drug effect or reduction of EPS?
    Weiser M; Shneider-Beeri M; Nakash N; Brill N; Bawnik O; Reiss S; Hocherman S; Davidson M
    Schizophr Res; 2000 Dec; 46(2-3):81-9. PubMed ID: 11120419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.
    van Veelen NM; Grootens KP; Peuskens J; Sabbe BG; Salden ME; Verkes RJ; Kahn RS; Sitskoorn MM
    Schizophr Res; 2010 Jul; 120(1-3):191-8. PubMed ID: 20493663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of olanzapine treatment on cognitive functions in patients with schizophrenia].
    Radziwiłłowicz P; Radziwiłłowicz W; Lis J
    Psychiatr Pol; 2002; 36(6):967-87. PubMed ID: 12725025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive improvement in schizophrenia with novel antipsychotic medications.
    Purdon SE
    Schizophr Res; 1999 Mar; 35 Suppl():S51-60. PubMed ID: 10190225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.
    Purdon SE; Jones BD; Stip E; Labelle A; Addington D; David SR; Breier A; Tollefson GD
    Arch Gen Psychiatry; 2000 Mar; 57(3):249-58. PubMed ID: 10711911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.